Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greene

Showing results (921-930 of 1,076) with videos related to

Pageof 108
Sort By:
The American Journal of Cardiology|May 9, 2017
Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network)Andrew P Ambrosy, Ankeet S Bhatt, Dianne Gallup, et al.
Cardio-Oncology (London, England)|May 29, 2026
Unveiling temporal trends and disparities in mortality with co-listed coronary artery disease and cancer, 1999-2024: insights from the CDC WONDER multiple cause of death databaseSaifullah Khan, Muhammad Hussain, Muhammad Hassan, et al.
JAMA|November 9, 2015
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized TrialMihai Gheorghiade, Stephen J Greene, Javed Butler, et al.
Nature Communications|June 2, 2022
Macrophages disseminate pathogen associated molecular patterns through the direct extracellular release of the soluble content of their phagolysosomesCatherine J Greene, Jenny A Nguyen, Samuel M Cheung, et al.
Proteomics|January 24, 2006
Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradationGustavo A de Souza, Lyris M F Godoy, Veronica R Teixeira, et al.
Circulation. Heart Failure|December 15, 2012
Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trialDavid E Lanfear, Hani N Sabbah, Steven R Goldsmith, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 9, 2023
Thalamo-cortical and cerebello-cortical functional connectivity in developmentCarolina Badke D'Andrea, Scott Marek, Andrew N Van, et al.
Journal of Cardiac Failure|August 24, 2021
Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection FractionMuthiah Vaduganathan, Gregg C Fonarow, Stephen J Greene, et al.
Circulation. Heart Failure|October 22, 2021
Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure RegistryMuhammad Shahzeb Khan, Stephen J Greene, Anne S Hellkamp, et al.
Circulation. Heart Failure|September 18, 2024
Equity in Heart Failure Care: A Get With the Guidelines Analysis of Between- and Within-Hospital Differences in Care by Sex, Race, Ethnicity, and InsuranceAlexander T Sandhu, Maria V Grau-Sepulveda, Celeste Witting, et al.
Pageof 108

Showing results (921-930 of 1,076) with videos related to

Sort By:
Pageof 108
The American Journal of Cardiology|May 9, 2017
Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network)Andrew P Ambrosy, Ankeet S Bhatt, Dianne Gallup, et al.
Cardio-Oncology (London, England)|May 29, 2026
Unveiling temporal trends and disparities in mortality with co-listed coronary artery disease and cancer, 1999-2024: insights from the CDC WONDER multiple cause of death databaseSaifullah Khan, Muhammad Hussain, Muhammad Hassan, et al.
JAMA|November 9, 2015
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized TrialMihai Gheorghiade, Stephen J Greene, Javed Butler, et al.
Nature Communications|June 2, 2022
Macrophages disseminate pathogen associated molecular patterns through the direct extracellular release of the soluble content of their phagolysosomesCatherine J Greene, Jenny A Nguyen, Samuel M Cheung, et al.
Proteomics|January 24, 2006
Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradationGustavo A de Souza, Lyris M F Godoy, Veronica R Teixeira, et al.
Circulation. Heart Failure|December 15, 2012
Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trialDavid E Lanfear, Hani N Sabbah, Steven R Goldsmith, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 9, 2023
Thalamo-cortical and cerebello-cortical functional connectivity in developmentCarolina Badke D'Andrea, Scott Marek, Andrew N Van, et al.
Journal of Cardiac Failure|August 24, 2021
Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection FractionMuthiah Vaduganathan, Gregg C Fonarow, Stephen J Greene, et al.
Circulation. Heart Failure|October 22, 2021
Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure RegistryMuhammad Shahzeb Khan, Stephen J Greene, Anne S Hellkamp, et al.
Circulation. Heart Failure|September 18, 2024
Equity in Heart Failure Care: A Get With the Guidelines Analysis of Between- and Within-Hospital Differences in Care by Sex, Race, Ethnicity, and InsuranceAlexander T Sandhu, Maria V Grau-Sepulveda, Celeste Witting, et al.
Pageof 108